Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: J Immunol. 2013 Jan 25;190(5):2455–2463. doi: 10.4049/jimmunol.1201314

Figure 7. Summary of mechanisms of chNKG2D T cell-mediated anti-tumor angiogenesis.

Figure 7

Inside the tumor, chNKG2D T cells can directly target NKG2D ligand-positive tumor cells, tumor vasculature as well as angiogenesis-promoting MDSC and Treg, leading to less angiogenesis and reduced tumor growth. Both chNKG2D T cell-derived IFN-γ and perforin are involved in the inhibition. See text for details.